China Pharma (CPHI) vs Grace Therapeutics (GRCE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Grace Therapeutics (GRCE) has outperformed China Pharma (CPHI) over the past year, losing 32.0% versus a loss of 51.8%. Over five years, GRCE leads with a -80.5% price change compared with -99.7% for CPHI. Grace Therapeutics is the larger company by market cap ($42.9 million vs $41.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CPHI | GRCE |
|---|---|---|
| Share price | $0.96 | $2.04 |
| Market cap | $41.30M | $42.91M |
| 1-day change | +12.94% | -2.86% |
| YTD return | -20.66% | -41.04% |
| 1-year return | -51.76% | -32.00% |
| 5-year return | -99.65% | -80.46% |
| EPS (TTM) | $-0.42 | $-1.17 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.19 | $5.18 |
| 52-week low | $0.38 | $1.79 |
| Distance from 52-week high | -95.00% | -60.62% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +187.75% |
| Average volume | 5.81M | 171.87K |
| Shares outstanding | 43.02M | 21.04M |
| Employees | 215 | 5 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GRCE has outperformed CPHI by 19.8 percentage points over the past year.
About China Pharma
CPHI stock →China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China.
Healthcare · Drug Manufacturers - Specialty & Generic · 215 employees
About Grace Therapeutics
GRCE stock →Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
Healthcare · Biotechnology · 5 employees
CPHI vs GRCE FAQ
Which is bigger, China Pharma or Grace Therapeutics?
Grace Therapeutics (GRCE) is larger, with a market capitalization of $42.91M compared with $41.30M for China Pharma (CPHI).
Which stock has performed better over the past year, CPHI or GRCE?
GRCE returned -32.00% over the past 12 months, compared with -51.76% for CPHI (price return, excluding dividends). Past performance does not predict future results.
Are China Pharma and Grace Therapeutics in the same industry?
Both are in the Healthcare sector, but in different industries: Drug Manufacturers - Specialty & Generic for China Pharma and Biotechnology for Grace Therapeutics.